Latest News

Fluorescent compounds allow clinicians to visualize Alzheimer's disease as it progresses

What if doctors could visualize all of the processes that take place in the brain during the development and progression of Alzheimer's disease? Such a window would provide a powerful aid for diagnosing the condition. Now, researchers have developed a new class of imaging agents that enables them to visualize tau protein aggregates, a pathological hallmark of Alzheimer's disease and related neurodegenerative disorders, directly in the brains of living patients.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Fear, safety and the role of sleep in human PTSD: Fragmented REM sleep may hinder effective treatment

  • Study reveals drivers of Western consumers' readiness to eat insects

  • Computer games give a boost to English

  • How nerve cells communicate with each other over long distances: Travelling by resonance

  • Serotonin deficiency? Study throws into question long-held belief about depression

  • Marijuana compound may offer treatment for Alzheimer's disease, study suggests

  • Gang life brings deep health risks for girls

  • First study of brain activation in multiple sclerosis using fNIRS

  • Readers with dyslexia have disrupted network connections in the brain, map the circuitry of dyslexia shows

  • Avatars make the Internet sign to deaf people

  •